Literature DB >> 21991960

Mortality after fluid bolus in African children with sepsis.

Stephen R Ford, Anil Visram.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21991960     DOI： 10.1056/NEJMc1108712

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  A trial to determine whether septic shock-reversal is quicker in pediatric patients randomized to an early goal-directed fluid-sparing strategy versus usual care (SQUEEZE): study protocol for a pilot randomized controlled trial.

Authors:  Melissa J Parker; Lehana Thabane; Alison Fox-Robichaud; Patricia Liaw; Karen Choong
Journal:  Trials       Date:  2016-11-22       Impact factor: 2.279

Review 2.  Personalised fluid resuscitation in the ICU: still a fluid concept?

Authors:  Frank van Haren
Journal:  Crit Care       Date:  2017-12-28       Impact factor: 9.097

Review 3.  Fluid resuscitation in human sepsis: Time to rewrite history?

Authors:  Liam Byrne; Frank Van Haren
Journal:  Ann Intensive Care       Date:  2017-01-03       Impact factor: 6.925

Review 4.  Mortality after fluid bolus in children with shock due to sepsis or severe infection: a systematic review and meta-analysis.

Authors:  Nathan Ford; Sally Hargreaves; Leslie Shanks
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

5.  Translating resuscitation guidelines into practice: health care provider attitudes, preferences and beliefs regarding pediatric fluid resuscitation performance.

Authors:  Melissa J Parker; Asmaa Manan
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

6.  Anaemia and blood transfusion in African children presenting to hospital with severe febrile illness.

Authors:  Sarah Kiguli; Kathryn Maitland; Elizabeth C George; Peter Olupot-Olupot; Robert O Opoka; Charles Engoru; Samuel O Akech; Richard Nyeko; George Mtove; Hugh Reyburn; Michael Levin; Abdel G Babiker; Diana M Gibb; Jane Crawley
Journal:  BMC Med       Date:  2015-02-02       Impact factor: 11.150
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.